Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.

Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.

Item
http://www.wikidata.org/entity/Q35137255
Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteersComparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers.Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial speciesPharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy.Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials.Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococciPharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults.Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjectsThe new fluoroquinolones: A critical reviewComparison of the effects of levofloxacin on QT/QTc interval assessed in both healthy Japanese and Caucasian subjects (pagesDoes Critical Illness Change Levofloxacin Pharmacokinetics?Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns.Use of the respiratory fluoroquinolones for the outpatient management of community-acquired pneumoniaIn vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous dosesIdentifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.
P2860

Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.

Item
http://www.wikidata.org/entity/Q35137255
description
1997 nî lūn-bûn
@nan
1997 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Absence of age and gender effe ...... ofloxacin in healthy subjects.
@ast
Absence of age and gender effe ...... ofloxacin in healthy subjects.
@en
type
label
Absence of age and gender effe ...... ofloxacin in healthy subjects.
@ast
Absence of age and gender effe ...... ofloxacin in healthy subjects.
@en
prefLabel
Absence of age and gender effe ...... ofloxacin in healthy subjects.
@ast
Absence of age and gender effe ...... ofloxacin in healthy subjects.
@en
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932
P1433
P1476
Absence of age and gender effe ...... ofloxacin in healthy subjects.
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932